GlaxoSmithKline Consumer Healthcare Australia Pty Ltd—Children’s Panadol 5-12 Suspension (Strawberry and Orange) 200mL
What are the defects?
There is a possibility of a small quantity of particulate contamination in an ingredient that is used to manufacture the products listed above.
What are the hazards?
An ingredient used in the manufacture of these medicines may have been contaminated with small particles that could contain trace minerals and inert fibres. If this occurs, there is a very low risk of allergic reaction and there is also potential for the medicine to be less effective over time.
What should consumers do?
If consumers have a bottle of any of the three batches listed above, they should not use it. They are instructed to return it to the place of purchase for a refund or call GlaxoSmithKline's customer service line for further information and support.
GlaxoSmithKline Consumer Healthcare: 1800 028 533.
All pharmacies across Australia.
- 4 April 2016 - 19 May 2016
Recall advertisements and supporting documentation
Therapeutic Goods Administration is the responsible regulator for this recall.